Published: 17 September, 2020 | Volume 4 - Issue 1 | Pages: 011-023
Figure 2:
2: A representation of tumour components transported from a glioma into CSF and peripheral blood. (A) GBM disrupts the BBB allowing circulating biomarkers to enter peripheral blood. Alternatively, tumour proximity to a CSF-containing space obviates the need for passage through the BBB, allowing a potentially higher yield in CSF. (B) Detailed composition of the tumoural components detectable in the circulation. Several classes of molecules can be captured and studied, including CTC’s, extracellular vesicles, ct-DNA, mRNA and miRNA. These carry information such as mutational status, epigenetic changes such as methylation, and chromosomal abnormalities which can be sampled non-invasively.
Read Full Article HTML DOI: 10.29328/journal.apcr.1001018 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."